Summary

Other Scenarios:

Buyer: Alcon, Inc. (ACL) Last Price: 167.99 Market Cap.: 50.80B
Target: Baxter International Inc. (BAX) Last Price: 53.73 Market Cap.: 30.83B

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
Healthcare 792
Biopharmaceuticals 347
Healthcare Services   139
Medical Devices 197
Nutritional Health 31
Outsourced Biomedical Services   41

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 128)
  • BioSorb Sutures
  • OcuScan RxP Ophthalmic Ultrasound System
  • Ultrascan Imaging System
  • EYEMAP EH-290 Corneal Topography System
Target (Total: 148)
  • Physiometrix Patient State Analyzer (PSA) 4000
  • Baxter Breathing Bag Series
  • Ultra-Fit Anesthesia Face Mask Series
  • Baxter Renal Care
Buyer
  • Emadine (Emedastine Difumarate)
  • Patanol (Olopatadine Hydrochloride)
  • Pataday (Olopatadine Hydrochloride)
  • Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate)
Target
  • Phenergan (Promethazine)
  • Diphenhydramine
  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 6)
  • Bayer AG (ADR) (BAYRY)
  • Allergan, Inc. (AGN)
  • Landec Corporation (LNDC)
  • Synergetics USA Inc. (SURG)
Target (Total: 11)
  • CA, Inc. (CA)
  • Ariba, Inc. (ARBA)
  • Nektar Therapeutics (NKTR)
  • Halozyme Therapeutics, Inc. (HALO)
Buyer (Total: 2)
  • LCA-Vision Inc. (LCAV)
  • PT Tempo Scan Pacific Tbk (PEXXF)
Target (Total: 12)
  • DaVita Inc. (DVA)
  • United Therapeutics Corporation (UTHR)
  • Amylin Pharmaceuticals, Inc. (AMLN)
  • Cerus Corporation (CERS)

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 16,700 48,000
Revenue Per Employee 435,204.3 292,300.8
Total Revenue 1,812.0 3,498.0
Total Expenses 1,236.0 3,037.0
Other Revenue 0.0 0.0
Cost of Revenue 435.0 1,880.0
SG&A Expense 559.0 708.0
Research & Development 210.0 228.0
Other Operating Expense 11.0 0.0
Operating Income 576.0 461.0
Unusual Income 0.0 221.0
LT Debt to Capital 0 39.92
Fwd P/E 17.87 11.57
Fwd P/Rev 6.59 2.29
Book Value 7,252.0 6,567.0
Curr Portion of LTD/Cap Lease 62.0 9.0

Individual Company Summary

Focused

Buyer

Focused (): Healthcare > Medical Devices > Ophthalmology

Target

Focused (): Healthcare > Medical Devices

Business Description

Buyer

Alcon, Inc. is a research and development global medical specialty company focused on eye care. The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat primarily diseases and disorders of the eye. It develops, manufactures and markets a range of prescription ophthalmic pharmaceutical products. The Company operates in two business segments: Alcon United States and Alcon International. Its portfolio includes three principal ophthalmic categories: pharmaceutical, surgical and consumer eye care products. On September 15, 2009, the Company acquired ESBATech AG, a Swiss biotechnology company. On January 6, 2010, the Company acquired Optonol, Ltd., a medical device company that develops, manufactures and markets miniature surgical implants. With this acquisition, Alcon acquired Optonol?s Ex-PRESS Mini Glaucoma Shunt.

Target

Baxter International Inc. (Baxter) through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter manufactures products in 27 countries and sells them in more than 100 countries. The Company operates in three segments: BioScience, Medication Delivery and Renal. Baxter generates approximately 60% of its revenues outside the United States, and maintains manufacturing and distribution facilities in a number of locations in the United States, Europe, Canada, Asia-Pacific and Latin America. In August 2009, the Company acquired certain assets of Edwards Lifesciences Corporation related to the hemofiltration business, also known as Continuous Renal Replacement Therapy (Edwards CRRT).

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 76.67 46.39
Operating Margin % 34.48 16.15
Quick Ratio 2.73 1.22
Current Ratio 3.39 1.98
Coverage Ratio 0.01 -0.04
Total Assets 10,073.0 17,489.0
Return on Equity % 30.47 21.73
Return on Assets % 21.94 8.16
Cash+ ST Inv. Per Share 11.19 4.58
Total Debt 399.0 4,387.0
Total Debt to Equity % 5.5 66.8
Total Debt to Tangible Equity % 7.3 97.04
Debt to Asset % 3.96 25.08

Product Summary

Sector Buyer Target
Healthcare
Biopharmaceuticals
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
  
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
  
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
  
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
  
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
  
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
  
Ophthalmology
The Ophthalmology Subsector includes therapeutics that treat eye disorders, infections, inflammations and irritations.
  
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
  
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
  
Healthcare Services  
Patient Care
The Patient Care Subsector is comprised of companies that provide services to patients for the diagnosis, treatment, and/or prevention of diseases and injuries.
  
Medical Devices
Anesthesiology
The Anesthesiology Subsector includes medical devices that deliver and monitor anesthetics.
  
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
  
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
  
Gastroenterology
The Gastroenterology Subsector includes medical devices that diagnosis and treat conditions affecting the stomach and intestinal tract.
  
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
  
Neurology
The Neurology Subsector includes medical devices that diagnose, monitor and treat neurological disorders.
  
Ophthalmology
The Ophthalmology Subsector includes medical devices that diagnose and treat eye disorders.
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
  
Radiology
The Radiology Subsector includes medical devices that generate images of internal physiology.
  
Respiratory
The Respiratory Subsector includes medical devices that diagnose and treat respiratory diseases.
  
Transfusion Medicine
The Transfusion Medicine Subsector includes medical devices and accessories that prepare or implement blood transfusion.
  
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
  
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
  
Nutritional Health
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
Outsourced Biomedical Services  
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
Healthcare
Biopharmaceuticals
Allergies
Dermatology  
Antihistamines
Products that inhibit inflammation by blocking the action of histamines on tissues.

Target Products:

  • Phenergan (Promethazine)
  
Ophthalmology
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.

Target Products:

  • Phenergan (Promethazine)
  
Antihistamines/Mast Cell Stabilizers
Therapeutics that treat allergy symptoms by inhibiting the release of histamine and other immune mediators.

Buyer Products:

  • Emadine (Emedastine Difumarate)
  • Patanol (Olopatadine Hydrochloride)
  • Pataday (Olopatadine Hydrochloride)
  • Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate)
  
Mast Cell Stabilizers
Therapeutics that treat allergic reactions by inhibiting the release of chemical mediators from sensitized mast cells.

Buyer Products:

  • Alomide (Lodoxamide Tromethamine)
  • Ketotifen Fumarate Ophthalmic Solution
  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that counteract or suppress inflammation preventing cyclooxygenase activity.

Buyer Products:

  • Ketorolac Tromethamine
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for treatment of allergic reactions in early stages of clinical research where human subject is involved.

Buyer Products:

  • POT-4 (Complement Inhibitor)
  
Upper Respiratory
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Nasal Patanase (Olopatadine Hydrochloride)

Target Products:

  • Phenergan (Promethazine)
  • Diphenhydramine
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Target Products:

  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Target Products:

  • Promethazine Hydrochloride/Phenylephrine Hydrochloride
  • Phenergan VC (Promethazine Hydrochloride/Phenylephrine Hydrochloride)
  
Cardiovascular System  
Heart Disorders  
Angina  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.

Target Products:

  • Propranolol Hydrochloride
  • Atenolol
  
Arrhythmia  
Adenosine A1 Receptor Agonists
Therapeutics that treat abnormal rhythm of the heart beat by selectively stimulating the A1 adenosine receptor, slowing the speed of AV nodal conduction

Target Products:

  • Adenosine
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat abnormal rhythm of the heart beat by inhibiting the stimulation of beta adrenergic receptors of the heart muscle.

Target Products:

  • Baxter BioScience Brevibloc (Esmolol HCl)
  • Propranolol Hydrochloride
  • Acebutalol Hydrochloride
  
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.

Target Products:

  • Quinidine Sulfate ER
  
Heart Failure (HF)  
Complications  
Edema  
Loop Diuretic Agents
Therapeutics that treat the excessive accumulation of fluids by increasing the excretion of sodium, potassium, chloride ions, and water in urine.

Target Products:

  • Baxter Healthcare Bumetanide
  
Myocardial Infarction (MI)  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat irreversible damage to the heart muscle by blocking the beta adrenergic receptors of the heart muscle.

Target Products:

  • Propranolol Hydrochloride
  • Atenolol
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in early stages of clinical research where human subject is involved.

Target Products:

  • CD34+ Cells (Adult Stem Cells)
  
Vascular Disorders  
Deep Vein Thrombosis (DVT)  
Anticoagulating Agents (Anticoagulants)  
Thrombin Inhibitors
Therapeutics that prevent or treat clots in blood vessels by preventing blood clots from forming.

Target Products:

  • Heparin Sodium
  
Hypertension  
Alpha Adrenergic Receptor Agonists
Therapeutics that treat high blood pressure by stimulating the alpha adrenergic receptors of the heart muscle.

Target Products:

  • Guanfacine
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.

Target Products:

  • Propranolol Hydrochloride
  • Atenolol
  • Acebutalol Hydrochloride
  
Hypovolemia  
Plasma Volumizers  
Albumin-Based
Therapeutics based on plasma proteins that treat a decrease in circulating fluid (plasma) in the body by increasing plasma volume.

Target Products:

  • Baxter BioScience Flexbumin (Albumin)
  • Baxter BioScience Buminate (Albumin)
  
Thromboembolism  
Anticoagulating Agents (Anticoagulants)  
Platelet Aggregation Inhibitors  
Phosphodiesterase Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing platelets from clumping together.

Target Products:

  • Dipyridamole
  
Thrombin Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing blood clots from forming.

Target Products:

  • Heparin Sodium
  
Digestive System  
Gastrointestinal Tract Disorders  
Gastroesophageal Disorders  
Gastroesophageal Reflux Disease (GERD)  
Dopamine Receptor Blocking Agents
Therapeutics that treat Gastroesophageal Reflux Disease (GERD) by blocking dopamine receptor and stimulating gastrointestinal movement without stimulating secretions from the pancreas, stomach or gall bladder.

Target Products:

  • Metoclopramide Hydrochloride
  
Nausea/Vomiting  
Serotonin Receptor Antagonists
Therapeutics that treat nausea and vomiting by blocking the serotonin receptors.

Target Products:

  • Ondansetron Injection
  • Granisetron Hydrochloride
  
Endocrinology/Metabolism  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.

Target Products:

  • PROMAXX Microsphere Dry Powder Inhaled Insulin
  
Hematology  
Hemophilia  
Hemophilia A  
Clotting Agents
Therapeutics that aid in blood coagulation.

Target Products:

  • Baxter BioScience FEIBA VH (Immuno Anti-Inhibitor Coagulant Complex)
  • Baxter BioScience Advate/Ultra-High Dosage ADVATE (Antihemophilic Factor VIII, Plasma/Albumin Free Method (rAHF-PFM))
  • Baxter BioScience Hemofil M (Antihemophilic Factor (Human))
  
Hemophilia B  
Clotting Agents
Therapeutics that assist in blood coagulation.

Target Products:

  • Baxter BioScience FEIBA VH (Immuno Anti-Inhibitor Coagulant Complex)
  • Baxter BioScience Proplex T (Factor IX Complex)
  
Red Blood Cell (RBC) Disorders  
Anemia  
Recombinant Human Erythropoietins
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues by stimulating red blood cell production.

Target Products:

  • Baxter BioScience Epoetin Omega
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in very early stages of research where no human subject is involved.

Target Products:

  • Long-Acting Recombinant Factor IX
  • Recombinant Protein ADAMTS13
  • AV513 (Non-Anticoagulant Sulfated Polysaccharide)
  • Baxter Healthcare Recombinant Factor VIII (Von Willebrand Factor (VWF)) Therapeutic Progarm
  
Serum Factor Disorders  
Hypoalbuminemia  
Albumin-Based
Therapeutics based on plasma proteins that treat low levels of serum albumin.

Target Products:

  • Baxter BioScience Flexbumin (Albumin)
  • Baxter BioScience Buminate (Albumin)
  • Baxter BioScience Albumin
  
Immunology  
Autoimmune Disorders  
Arthritis  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Target Products:

  • Etodolac
  
Idiopathic Thrombocytopenia Purpura (ITP)  
Immunoglobulins
Therapeutics that treat a decrease in platelets by neutralizing autoantibodies with therapeutic antibodies.

Target Products:

  • Baxter BioScience WinRho SDF (Rho Immunoglobulin Lyophilized/Liquid Form)
  • Baxter BioScience IVEEGAM EN/Gamimune N (Immune Globulin)
  • Baxter BioScience IVEEGAM (Immune Globulin)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Kawasaki Syndrome  
Immunoglobulins
Therapeutics that treat Kawasaki Syndrome by neutralizing autoantibodies with therapeutic antibodies.

Target Products:

  • Baxter BioScience IVEEGAM EN/Gamimune N (Immune Globulin)
  • Baxter BioScience IVEEGAM (Immune Globulin)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Immune Deficiency Disorders  
Primary Immunodeficiency Diseases  
Immunoglobulins
Therapeutics that treat primary immunodeficiency diseases by providing the body with therapeutic antibodies.

Target Products:

  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Immunoglobulins/Hyaluronic Acid
Therapeutics that treat primary immunodeficiency diseases by providing therapeutic antibodies administered simultaneously with hyaluronic acid.

Target Products:

  • GAMMAGARD/rHuPH20 (Immune Globulin/Human Hyaluronidase Enzyme)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in very early stages of research where no human subject is involved.

Target Products:

  • Recombinant ADAMTS13
  
Infectious Diseases
Bacterial
Antibacterial Agents
Broad Spectrum  
Antibiotics  
Aminoglycosides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.

Target Products:

  • Gentamicin Surgical Implant
  
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Target Products:

  • Baxter Healthcare Cefepime
  • Ceftriaxone Sodium
  
Penicillin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis during active multiplication.

Target Products:

  • Bactocill
  
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.

Target Products:

  • Baxter Healthcare Ciprofloxacin In Dextrose Solution
  
Tetracyclines
Therapeutics that treat a wide variety of infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.

Target Products:

  • Minocycline Hydrochloride
  
Narrow Spectrum
Ophthalmology  
Blepharitis (Eyelid Inflammation)  
Aminoglycosides
Therapeutics that treat inflammation of the eyelid by inhibiting bacterial protein synthesis.

Buyer Products:

  • Falcon Gentamicin Sulfate Ophthalmic Solution
  
Conjunctivitis  
Mast Cell Stabilizers
Therapeutics that treat inflammation of the clear membrane outside the eye preventing the mast cell release of histamine.

Buyer Products:

  • Falcon Cromolyn Sodium Ophthalmic Solution
  
Quinolones/Fluoroquinolones
Therapeutics that treat inflammation of the clear membrane outside the eye by promoting breakage of bacterial DNA strands.

Buyer Products:

  • Ciloxan (Ciprofloxacin Hydrochloride)
  • Ofloxacin
  
Keratitis  
Mast Cell Stabilizers
Therapeutics that treat inflammation of the cornea caused by bacterial infection by inhibiting the release of histamine and leukotrienes from mast cells.

Buyer Products:

  • Falcon Cromolyn Sodium Ophthalmic Solution
  
Keratoconjunctivitis  
Mast Cell Stabilizers
Therapeutics that treat inflammation of the cornea and the clear membrane outside the eye caused by bacterial infection by blocking the release of histamines from mast cells.

Buyer Products:

  • Falcon Cromolyn Sodium Ophthalmic Solution
  
Ocular Infections  
Aminoglycosides
Therapeutics that treat bacterial infections of the eye by inhibiting bacterial protein synthesis.

Buyer Products:

  • Tobrex (Tobramycin Sulfate)
  • Falcon Tobramycin Ophthalmic Solution
  
Aminogylcosides/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat bacterial infections of the eye by inhibiting bacterial protein synthesis and suppressing the full immune response.

Buyer Products:

  • Tobradex ST (Tobramycin/Dexamethasone)
  • CiproDex Ocular (Ciprofloxacin/Dexamethasone)
  • New Formulation Tobramycin/Dexamethasone
  • Tobradex (Tobramycin/Dexamethasone)
  
Diaminopyrimidines/Polypeptides
Therapeutics that treat bacterial infections of the eye by inhibiting folic acid synthesis and damaging the cell membrane.

Buyer Products:

  • Falcon Trimethoprim Sulfate/Polymyxin B Sulfate Ophthalmic Solution
  
Quinolones/Fluoroquinolones
Therapeutics that treat general inflammation/infections of the eye by promoting breakage of bacterial DNA strands.

Buyer Products:

  • Falcon Ciprofloxacin Hydrochloride
  • Moxeza (Moxifloxacin)
  • Vigamox (Moxifloxacin Hydrochloride)
  • Ciloxan (Ciprofloxacin Hydrochloride)
  • New Formulation Moxifloxacin
  
Otolaryngology (Ear/Nose/Throat)  
External Ear Canal Infections  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotic)
Therapeutics that treat bacterial infections of the external auditory canal with a steroidal compound and by killing or inhibiting the growth of microorganisms.

Buyer Products:

  • Otic Moxafloxacin/Dexamethasone
  • CiproDex Otic (Ciprofloxacin/Dexamethasone)
  • Cipro HC Otic (Ciprofloxacin HCl/Hydrocortisone Otic)
  • Falcon Neomycin/Polymyxin B/Hydrocortisone Otic Suspension
  
Otitis Media  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotic)
Therapeutics that treat bacterial infections of the middle ear with a steroidal compound and by killing or inhibiting the growth of microorganisms.

Buyer Products:

  • Otic Moxafloxacin/Dexamethasone
  • CiproDex Otic (Ciprofloxacin/Dexamethasone)
  
Respiratory System  
Bronchitis  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Target Products:

  • Sulfamethoxazole/Trimethoprim
  
Pneumonia  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat inflammation of the lungs caused by bacterial infection by inhibiting folic acid synthesis and bacterial growth.

Target Products:

  • Sulfamethoxazole/Trimethoprim
  
Tuberculosis  
Antitubercular Agents
Therapeutics that treat a bacterial infection of the lung by inhibiting bacterial and mycobacterial RNA synthesis.

Target Products:

  • Pyrazinamide
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections of the urinary tract by inhibiting dihydrofolate reductase resulting in decreased bacterial nucleic acid/protein production.

Target Products:

  • Sulfamethoxazole/Trimethoprim
  
Vaccines  
Bacterial  
Combination  
Diphtheria/Tetanus/Acellular Pertussis (DTaP)
Therapeutics that prevent or treat infectious disease by producing or artificially increasing immunity to pathogens that cause diphtheria, tetanus, and acellular pertussis.

Target Products:

  • Baxter BioScience Certiva (DTaP)
  
Mycological (Fungal)  
Antifungal Agents  
Narrow Spectrum  
Dermatology  
Tinea Barbae  
Penicillin Derivatives
Therapeutics that treat fungal infections of the bearded area by inhibiting the biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Tinea Capitis  
Penicillin Derivatives
Therapeutics that treat fungal infections of the scalp by inhibiting biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Tinea Corporis (Ringworm)  
Penicillin Derivatives
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by inhibiting the biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Tinea Cruris (Jock Itch)  
Penicillin Derivatives
Therapeutics that treat fungal infections of the groin and perineum by inhibiting the biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Tinea Pedis  
Penicillin Derivatives
Therapeutics that treat fungal infections of the feet by inhibiting the biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Tinea Unquium  
Penicillin Derivatives
Therapeutics that treat fungal infections of the nails by inhibiting the biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Tinea Versicolor  
Penicillin Derivatives
Therapeutics that treat fungal infections of skin exposed to the sun characterized by patches of depigmentation by inhibiting the biosynthesis of cell walls.

Target Products:

  • Griseofulvin
  
Nervous System  
Cryptococcal Meningitis  
Triazoles
Therapeutics that treat fungal infections of lining of the brain and the spinal cord by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Target Products:

  • Fluconazole
  
Otolaryngology (Ear/Nose/Throat)  
Esophageal Candidiasis  
Triazoles
Therapeutics that treat fungal infections of the esophagus caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Target Products:

  • Fluconazole
  
Oropharyngeal Candidiasis  
Azoles  
Triazoles
Therapeutics that treat fungal infections of the mouth and pharynx caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Target Products:

  • Fluconazole
  
Urology  
Vaginal Candidiasis  
Azoles  
Triazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Target Products:

  • Fluconazole
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in early stages of clinical research where human subject is involved.

Buyer Products:

  • Moxifloxacin/Dexamethasone
  • NVC-422 (Aganase Compound)

Target Products:

  • Baxter Bioscience Vero Seasonal Influenza Vaccine
  • Baxter BioScience Haemophilus Influenzae Type B Vaccine
  • H5N1 Pandemic Influenza Vaccine
  • Baxter BioScience Acellular Pertussis (aP) Vaccine
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in very early stages of research where no human subject is involved.

Target Products:

  • Baxter BioScience Escherichia coli Vaccine
  
Viral
DNA Viruses
Herpesvirus
Herpes Simplex Type 1
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Target Products:

  • Acyclovir
  
Viral DNA Polymerase Inhibitors
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA blocking the action of an essential enzyme.

Buyer Products:

  • Falcon Trifluridine Ophthalmic Solution
  
Herpes Simplex Type 2
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Target Products:

  • Acyclovir
  
Viral DNA Polymerase Inhibitors
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by blocking the action of an essential enzyme.

Buyer Products:

  • Falcon Trifluridine Ophthalmic Solution
  
Varicella Zoster  
Herpes Zoster (Shingles)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause shingles in adults by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Target Products:

  • Acyclovir
  
Varicella (Chickenpox)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause chicken pox in children by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Target Products:

  • Acyclovir
  
Vaccines  
Viral  
Single Target  
Influenza (Flu)
Therapeutics that prevent or treat viral infections of the respiratory tract by producing or artificially increasing immunity to the Influenza virus.

Target Products:

  • Baxter Bioscience Vero Seasonal Influenza Vaccine
  
Musculoskeletal System  
Skeletal Disorders  
Joint Disorders  
Osteoarthritis (OA)  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Target Products:

  • Etodolac
  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Target Products:

  • Etodolac
  
Neurology  
Neurological Disorders  
Alzheimer`s Disease  
Immunoglobulins
Therapeutics that treat and manage Alzheimer's disease by providing a therapeutic protein.

Target Products:

  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  
Epilepsy  
Status Epilepticus  
Sodium Channel Modulators
Therapeutics that treat Status Epilepticus by modulating the portal that allows sodium into the nerve cells.

Target Products:

  • Fosphenytoin Sodium
  
Headaches  
Vascular (Migraine)  
Prophylactic Treatments  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat Migraine by inhibiting stimulation of beta adrenergic receptors.

Target Products:

  • Propranolol Hydrochloride
  
Neuromuscular Disorders  
Myasthenia Gravis (MG)  
Cholinesterase Inhibitors
Therapeutics that treat Myasthenia Gravis by maintaining the transmission of nerve impulses by inhibiting the enzyme that breaks down acetylcholine.

Target Products:

  • Baxter BioScience Enlon-Plus(R) (Edrophonium Chloride, USP & Atropine Sulfate, USP)
  • Baxter BioScience Enlon(R) (Edrophonium Chloride, USP)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of nervous system and mental disorders in early stages of clinical research where human subject is involved.

Target Products:

  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  
Psychiatric Disorders  
Anxiety  
Generalized Anxiety Disorder (GAD)  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat anxiety by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Target Products:

  • Lorazepam
  • Diazepam
  
Sleep Disorders  
Insomnia  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.

Target Products:

  • Diazepam
  
Oncology  
Breast Cancer  
Localized  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage breast cancers by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Hematology  
Leukemia (White Blood Cell Cancer)  
Lymphoid  
Acute  
Lymphoblastic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of immature lymphocytic cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Lymphocytic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of lymphocytic cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Chronic  
Lymphocytic (CLL)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage slowly progressing cancers of lymphocytic cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Immunoglobulins
Therapeutics that treat and manage slowly progressing cancers of lymphocytic cells by providing a therapeutic protein.

Target Products:

  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Myeloid  
Acute  
Monocytic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of mononuclear cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Myelogenous (AML)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of myelogenous cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Chronic  
Granulocytic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage slowly progressing cancers of myelocytic cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Lymphoma (Lymphatic Cancer)  
Cutaneous T-Cell Lymphoma (CTCL)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage T-Cell lymphomas of the skin by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Hodgkin`s Disease  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage lymphoma characterized by the presence of Reed-Sternberg cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Non-Hodgkin`s Lymphoma (NHL)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage lymphomas of B-cells and T-cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Multiple Myeloma (Plasma Cell Cancer)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of mature antibody producing white blood cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Neurology  
Brain Cancer  
Neuroblastoma  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancer of primitive ganglion cells by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Opthalmology  
Retinoblastoma  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of the retina by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Urology  
Ovarian Cancer  
Adenocarcinoma  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancer of cells lining the ovary by interacting with DNA and inhibiting cell division.

Target Products:

  • Cyclophosphamide Injection
  
Ophthalmology  
Degenerative Disorders  
Dry Eye  
Immunosuppressants
Therapeutics that suppress the immune system pathways that can lead to dryness of the eye.

Buyer Products:

  • Zyclorin (Cyclosporine Ophthalmic Solution)
  
Lubricants
Therapeutics that wet the eye and lubricate the eye.

Buyer Products:

  • Systane Lubricant Eye Drops
  • BSS Plus Solution
  • Navstel (Hypromellose/Dextrose/Glutathione)
  
Glaucoma  
Alpha Adrenergic Receptor Agonists
Therapeutics that decrease the formation and increase the outflow of the fluid of the eye.

Buyer Products:

  • Iopidine (Apraclonidine Hydrochloride)
  • Falcon Levobunolol Hydrochloride Ophthalmic Solution
  • Falcon Atropine Sulfate Ophthalmic Solution
  • Falcon Brimonidine Tartrate
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that decrease the formation of the fluid of the eye.

Buyer Products:

  • Falcon Timolol Maleate Ophthalmic Solution
  • Falcon Timolol GFS (Timolol Maleate Ophthalmic Gel Forming Solution)
  • Falcon Metipranolol Ophthalmic Solution
  • Falcon Carteolol Hydrochloride Ophthalmic Solution
  • Falcon Betaxolol Hydrochloride Ophthalmic Solution
  • Betoptic S (Betaxolol Hydrochloride)
  
Carbonic Anhydrase Inhibitors
Therapeutics that decrease the formation of the fluid of the eye.

Buyer Products:

  • Azopt (Brinzolamide)
  • Dorzolamide Hydrochloride Opthalmic Solution
  
Cholinergic Agents
Therapeutics that stimulate cholinergic receptors leading to decrease inflow and increased outflow of fluid of the eye.

Buyer Products:

  • Miostat (Carbachol Intraocular Solution)
  • Falcon Pilocarpine Hydrochloride Ophthalmic Solution
  
Prostanoid Selective FP Receptor Agonists
Therapeutics that increase the outflow of fluid of the eye.

Buyer Products:

  • Travatan Z (Travoprost Ophthalmic Solution)
  • Travatan (Travoprost)
  • Extravan (Travoprost/Timolol Fixed Combination)
  
Irritation/Inflammation  
Antibacterial Agents (Antibiotics)
Therapeutics that treat infections by inhibiting bacterial replication.

Buyer Products:

  • Falcon Ciprofloxacin Hydrochloride
  • Moxeza (Moxifloxacin)
  • Ofloxacin
  • Tobrex (Tobramycin Sulfate)
  • Vigamox (Moxifloxacin Hydrochloride)
  • Falcon Sulfacetamide Sodium Ophthalmic Solution
  • Ciloxan (Ciprofloxacin Hydrochloride)
  
Antibacterial Agents/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat infections by inhibiting bacterial replication as well as prevent cells that cause inflammation from adhering to the inflammation site.

Buyer Products:

  • Falcon Neomycin/Polymyxin B/Hydrocortisone Ophthalmic Suspension
  • Tobradex ST (Tobramycin/Dexamethasone)
  • Falcon Sulfacetamide Sodium And Prednisolone Sodium Phosphate Ophthalmic Solution
  • CiproDex Ocular (Ciprofloxacin/Dexamethasone)
  • Falcon Neomycin/Polymyxin B Sulfates/Dexamethasone Ophthalmic Suspension/Ointment
  • Tobradex (Tobramycin/Dexamethasone)
  • New Formulation Tobramycin/Dexamethasone
  • Maxitrol (Polymyxin B/Neomycin/Dexamethasone)
  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that counteract or suppress inflammation by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Nevanac (Nepafenac Ophthalmic Suspension)
  • Bromfenac Sodium
  • Ketorolac Tromethamine
  
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that counteract or suppress inflammation by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.

Buyer Products:

  • Falcon Dexamethasone Sodium Phosphate
  • Triesence (Triamcinolone Acetonide Injectable Suspension)
  • Falcon Prednisolone Acetate Ophthalmic Suspension
  • Vexol (Rimexolone)
  • Durezol (Difluprednate Ophthalmic Emulsion)
  
Uveitis  
Alpha Adrenergic Receptor Agonists
Therapeutics that treat inflammation of the uvea, the middle layer of the eye, by selectively binding and activating alpha adrenergic receptors

Buyer Products:

  • Falcon Phenylephrine Hydrochloride Ophthalmic Solution
  
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that counteract or suppress uveitis by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.

Buyer Products:

  • Triesence (Triamcinolone Acetonide Injectable Suspension)
  
Non-Degenerative Disorders  
Allergic Conjunctivitis  
Antihistamines/Mast Cell Stabilizers
Therapeutics that treat allergic conjunctivitis by inhibiting the release of histamine and other immune mediators from cells involved in allergic response.

Buyer Products:

  • Emadine (Emedastine Difumarate)
  • Pataday (Olopatadine Hydrochloride)
  • Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate)
  • Patanol (Olopatadine Hydrochloride)
  
Mast Cell Stabilizers
Therapeutics that treat infections by inhibiting the release of chemical mediators from sensitized mast cells.

Buyer Products:

  • Alomide (Lodoxamide Tromethamine)
  • Ketotifen Fumarate Ophthalmic Solution
  
Mydriasis (Acute Pupillary Dilation)  
Induction  
Anticholinergic Agents
Therapeutics that block the actions of choline and other cholinergic agents.

Buyer Products:

  • Falcon Tropicamide Ophthalmic Solution
  • Falcon Atropine Sulfate Ophthalmic Solution
  • Falcon Cyclopentolate Hydrochloride
  
Ocular Hypertension  
Alpha Adrenergic Receptor Agonists
Therapeutics that decrease the formation and increase the outflow of the fluid of the eye.

Buyer Products:

  • Falcon Levobunolol Hydrochloride Ophthalmic Solution
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that decrease the formation of the fluid of the eye.

Buyer Products:

  • Falcon Timolol GFS (Timolol Maleate Ophthalmic Gel Forming Solution)
  • Betoptic S (Betaxolol Hydrochloride)
  • Falcon Betaxolol Hydrochloride Ophthalmic Solution
  
Carbonic Anhydrase Inhibitors
Therapeutics that decrease the formation of the fluid of the eye.

Buyer Products:

  • Azopt (Brinzolamide)
  
Prostanoid Selective FP Receptor Agonists
Therapeutics that treat a condition characterized by increased pressure in the fluid of the eye by increasing the outflow of fluid of the eye.

Buyer Products:

  • Travatan Z (Travoprost Ophthalmic Solution)
  • Extravan (Travoprost/Timolol Fixed Combination)
  • Travatan (Travoprost)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of eye disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Glaucoma Compound
  • Retaane (Anecortave Acetate)
  • Moxifloxacin/Dexamethasone
  • Rimexolone Dry Eye Product
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of eye disorders in very early stages of research where no human subject is involved.

Buyer Products:

  • Cilomilast (PDE-4 Inhibitor)
  
Pain Management  
Anesthesia  
General (Systemic)  
Adjunctive  
Acetylcholine Blocking Agents
Therapeutics that inhibit neuromuscular activity by competing with acetylcholine at the cholinergic receptors resulting in neuromuscular blockage.

Target Products:

  • Atracurium Besylate
  
Ether-Based Agents
Therapeutics that result in anesthesia due to interfering with the physiological functioning of nerve cell membranes in the brain.

Target Products:

  • Baxter BioScience Suprane(R) (Desflurane, USP)
  • Baxter BioScience Ethrane(R) (Enflurane, USP)
  • Baxter BioScience Forane(R) (IsoFlurane, USP)
  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that result in anesthesia by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Target Products:

  • Midazolam
  • Diazepam
  
Hypnotic Agents (Sedatives)
Therapeutics that result in anesthesia by inducing sleep. These therapeutics have no analgesic action.

Target Products:

  • Propofol
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters both the perception of pain as well as the emotional response to pain.

Target Products:

  • Meperidine HCl
  • Sufentanil Citrate
  • Morphine Sulfate
  
Reversal  
Gamma-Aminobutyric Acid (GABA) Receptor Antagonists
Therapeutics that reverse general anesthesia by competitively inhibiting benzodiapizines at the GABA receptors, thus reducing their effect and reversing the anesthesia.

Target Products:

  • Flumazenil
  
Narcotics  
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.

Target Products:

  • Hydrocodone Bitartrate/Acetaminophen
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.

Target Products:

  • Sufentanil Citrate
  • Infumorph (Morphine Sulfate)
  • Morphine Sulfate
  
Non-Narcotics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.

Target Products:

  • Ketorolac Tromethamine
  • Etodolac
  
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.

Target Products:

  • Robaxin (Methocarbamol)
  
Respiratory System  
Lower Respiratory Tract Disorders (Lung Disorders)  
Bronchitis  
Complications  
Bacterial Infections  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Target Products:

  • Sulfamethoxazole/Trimethoprim
  
Emphysema  
Congenital  
Proteinase Inhibitors
Therapeutics that treat emphysema by providing certain proteins. The body's lack of ability to manufacture these proteins results in the disease state.

Target Products:

  • Glassia (Alpha-1 Proteinase Inhibitor)
  • Baxter Biosciences Aralast (Alpha-1 Proteinase Inhibitor)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of respiratory disorders in early stages of clinical research where human subject is involved.

Target Products:

  • Recombinant Alpha 1-Antitrypsin (AAT) Therapy
  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Target Products:

  • Phenergan (Promethazine)
  • Diphenhydramine
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Target Products:

  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and reduces the amount of mucous build up.

Target Products:

  • Promethazine Hydrochloride/Phenylephrine Hydrochloride
  • Phenergan VC (Promethazine Hydrochloride/Phenylephrine Hydrochloride)
  
Antihistamines/Decongestants/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation, preventing congestion and altering both the perception and emotional response to pain.

Target Products:

  • Phenergan VC With Codeine (Promethazine Hydrochloride/Phenylephrine Hydrochloride/Codeine Phosphate)
  
Antihistamines/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation and altering both the perception and emotional response to pain.

Target Products:

  • Phenergan With Codeine (Promethazine HCL/Codeine Phosphate)
  
Surgery
Cardiovascular System  
Thrombosis  
Thrombin Inhibitors
Therapeutics that thin the blood of a blocked blood vessel during surgery by blocking an enzyme involved in the clotting process.

Target Products:

  • Heparin Sodium
  
General  
Complications  
Hemorrhage  
Fibrinolysis Inhibitors
Therapeutics that treat complications involving bleeding after surgical procedures by inhibiting the breakdown of fibrin in blood clots.

Target Products:

  • Baxter BioScience Tisseel VH Kit (Two-Component Fibrin Sealant)
  
Thrombosis  
Anticoagulating Agents (Anticoagulants)  
Thrombin Inhibitors
Therapeutics used to control and treat blood clots by preventing the action of thrombin, a key enzyme involved in the clot formation process.

Target Products:

  • Heparin Sodium
  
Musculoskeletal System  
Deep Vein Thrombosis (DVT)  
Anticoagulating Agents (Anticoagulants)  
Thrombin Inhibitors
Therapeutics that treat vascular obstructions due to platelets and cell matter by blocking an enzyme involved in the clotting process.

Target Products:

  • Heparin Sodium
  
Neurology  
Seizures  
Sodium Channel Modulators
Therapeutics that treat seizures by controlling the entrance of sodium into the nerve cells.

Target Products:

  • Fosphenytoin Sodium
  
Ophthalmology  
Anesthesia  
Sodium Channel Blocking Agents
Therapeutics that act as local pain killer before specific, surgical procedures involving the removal of an ocular lens that has become opaque by controlling the entrance of sodium into the nerve cells.

Buyer Products:

  • Falcon Proparacaine Hydrochloride Ophthalmic Solution
  
Mydriasis (Acute Pupillary Dilation)  
Induction  
Anticholinergic Agents
Therapeutics used before surgical procedures involving the eyes that cause pupil dilation by blocking the actions of choline and other cholinergic agents.

Buyer Products:

  • Falcon Cyclopentolate Hydrochloride
  
Ocular Inflammation  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that counteract or suppress inflammation resulting from surgical procedures to remove cataracts by preventing cyclooxygenase activity.

Buyer Products:

  • Nevanac (Nepafenac Ophthalmic Suspension)
  • Ketorolac Tromethamine
  
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that counteract or suppress inflammation of the eye after surgery using a steroidal compound.

Buyer Products:

  • Triesence (Triamcinolone Acetonide Injectable Suspension)
  
Toxicology  
Substance Abuse  
Withdrawal  
Alcohol  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat alcohol withdrawal by increasing the effect of GABA at the relevant neuroreceptors.

Target Products:

  • Diazepam
  
Urology  
Urological Disorders  
Bladder  
Cystitis  
Urotoxin Neutralizing Agents
Therapeutics that inhibit cystis induced by toxic therapeutics by neutralizing these therapeutics.

Target Products:

  • Mesnex (Mesna)
  
Healthcare Services  
Patient Care  
Ambulatory/Outpatient  
Specialized  
Dialysis Services
The process of cleansing the blood of end stage renal disease patients (ESRD) through the use of a semipermeable membrane, which allows waste products to pass but retains most of the blood's normal constituents. Dialysis services can be provided in outpatient settings, in patients' home, or in hospitals as a contractor.

Target Products:

  • RMS Lifeline
  • RMS Disease Management
  • Baxter Renal Care
  
Medical Devices
Anesthesiology  
Diagnostic  
Monitoring  
Systems  
Consciousness Monitoring
Systems designed to monitor the effect of anesthesia on patients during surgery.

Target Products:

  • Physiometrix Patient State Analyzer (PSA) 4000
  
Surgical  
General Procedure  
Delivery Systems  
Gas  
Breathing Accessories
Ancillary devices used to aid the administering of inhaled anesthetics, such as breathing bags and breathing masks.

Target Products:

  • Baxter Breathing Bag Series
  • Ultra-Fit Anesthesia Face Mask Series
  
Breathing Circuits
Devices which assist in physical mechanism of breathing.

Target Products:

  • Baxter Renal Care
  • Baxter Isoflex Series Breathing Circuits
  
Percutaneous (Subcutaneous/Intramuscular/Intravenous)  
Fluid Administration Sets
Intravenous fluid administration sets used to deliver anesthesia.

Target Products:

  • Auto Syringe Pump Set Series
  
Pumps/Systems
Devices used to pump intravenous fluids at a consistent programmed rate.

Target Products:

  • Auto Syringe Pump Set Series
  
Viscoelastics
Materials that can be applied to the skin and decrease resistance of to injected drugs.

Target Products:

  • Hylenex (Recombinant Human Hyaluronidase)
  
Procedure/Region Specific  
Delivery Systems  
Epidural
Devices used to inject anesthetic into the epidural space to numb the legs and abdomen, which include catheters, needles, syringes and other prepackaged kits.

Target Products:

  • Single-Pack Epidural Needle Series
  • Continuous Double-Deck Epidural Anesthesia Tray Series
  
Nerve Block
Devices used to assist in the delivery of nerve block anesthetic, which include catheters, needles and other prepackaged kits.

Target Products:

  • Single-Deck Nerve Block Tray Series
  
Spinal
Devices used to inject anesthetic into the spine, which include catheters, needles and other prepackaged kits.

Target Products:

  • Single-Pack Epidural Needle Series
  • Continuous Double-Deck Epidural Anesthesia Tray Series
  
Cardiology  
Surgical  
General Procedure  
Accessories  
Vessel Closure
Devices used to close heart blood vessels.

Target Products:

  • Fusion Medical FloSeal FAST
  
Drug Delivery  
Infusion Therapy  
Accessories  
Admixture Systems
Medical systems designed to combine multiple medications for delivery to the patients

Target Products:

  • Clintec Automix(R) Compounder System and Accessory
  
Closed Blood Sampling Systems
Sampling systems which do not use needles to access infusion systems to obtain a blood sample.

Target Products:

  • Edwards VAMP
  
Filtration Products
Device used to filter fluids for infusion.

Target Products:

  • I.V. Filtration Set Series
  • Fenwal Blood Device And Set Series
  
Fluid Administration/Extension Sets
Filtered IV sets designed for infusion therapy.

Target Products:

  • Needle*Lock(TM) Device and Set Series
  • High Flow Rate Extension Set
  
Fluid Warmers
Medical devices used to maintain the warmth of the medical products prior to and during the infusion process.

Target Products:

  • ThermaCyl Blood/Fluid Warmer
  
Needleless Fluid Administration/Extension Sets
Valve systems designed to work without needles to prevent patient injuries.

Target Products:

  • Clearlink
  • Baxject Needleless Transfer Device
  
Pump Sets
Pump sets designed specifically for infusion therapy.

Target Products:

  • Auto Syringe Pump Set Series
  
Delivery Systems  
Elastomeric Infusors
Infusion delivery system designed for small-volume fluid transmission (home use).

Target Products:

  • Intermate Infusor System Series
  
Pumps  
Multiple Channel
Multiple channel pump designed to deliver more than one infusion therapy to patients.

Target Products:

  • COLLEAGUE Infusion Pump
  • Auto Syringe Pump Set Series
  
Single Channel
Single channel pump designed to deliver only one infusion therapy to patients.

Target Products:

  • Auto Syringe Pump Set Series
  
Syringe
Syringe used in place of a pump to deliver infusion therapy.

Target Products:

  • Syndeo PCA Syringe Pump
  • Auto Syringe Pump Set Series
  
Integrated/Comprehensive Systems
Complete infusion systems that include pumps, monitoring devices and other accessories.

Target Products:

  • Ipump Pain Management System
  
Vascular Access  
Peripheral Intravenous Catheters  
Infusion Sets
Complete infusion sets containing peripheral intravenous catheters.

Target Products:

  • Sub-Q-Set Subcutaneous Series
  • Micro-Volume Series
  
Standard
Non-ported peripheral intravenous catheters.

Target Products:

  • Interlink Flash-Cath Series
  
Gastroenterology  
Treatment  
Stomach  
Tubes  
Feeding
A tube that carries food to the stomach.

Target Products:

  • Clintec Dual Port Feeding Tube Series
  
General Surgery
Invasive
Surgical-Site Treatments
Anti-Adhesives/Anti-Scarring  
Gels
Gel-based products applied during interventional procedures to prevent adhesion to medical devices or to prevent scarring of the surgical site

Target Products:

  • ADEPT Adhesion Reduction Solution
  
Closure  
Sutures/Loops
Thread-like material used for stitching up an interventional area for surgical procedures, including both absorbable and non-absorbable materials. Sutures that biodegrade and are absorbed in the body after surgical procedures.

Buyer Products:

  • BioSorb Sutures
  
Sealants  
Adhesives
Glue based products used to seal tissue during surgical procedures

Target Products:

  • ARTISS (Human Fibrin Sealant)
  
Hemostatic  
Delivery Systems
Medical devices designed to deliver hemostatic sealants to the surgical site

Target Products:

  • Tissomat Application Device
  
Sponges
Microfibrillar sponge used when conventional hemostasis procedures are not effective.

Target Products:

  • Fusion Medical FloSeal Sponge
  
Topical
Topical mixture used when conventional hemostasis procedures are not effective.

Target Products:

  • TachoSil (Fibrin Sealant Patch)
  • Baxter BioScience Tisseel VH Kit (Two-Component Fibrin Sealant)
  • Fusion Medical FloSeal Matrix
  
Medical Supplies  
Diagnostic  
Clinical Examination  
Basic Examining Tools
Medical instruments used to examine and monitor basic physiological functions, such as reflex, blood pressure, heart rate, and pulmonary capacity. These instruments include stethoscopes, sphygmomanometers, percussion hammers and other similar items.

Target Products:

  • French Esophageal Stethoscope Series
  
Safety and Sterilization  
Safety  
Waste Management
Products used to control and contain biohazardous materials, such as chemical waste, fluid waste, and solid waste. These products may include bags, containers, and other more advanced waste treatment systems.

Target Products:

  • Bentley BosPac Plus
  
Treatment  
Wound Management  
Cleaning/Healing Devices
Devices used to clean and facilitate healing of wounds, such as bandages, dressings, cleansers, anti-infective ointments, sponges, cold compresses and other similar items.

Target Products:

  • GELFOAM Plus Hemostasis Kit (Human Thrombin Sponge)
  
Neurology  
Diagnostic  
Monitoring  
Monitors  
Electroencephalograph (EEG)  
Intraoperative
An electroencephalograph that is used during surgery.

Target Products:

  • Physiometrix Patient State Analyzer (PSA) 4000
  
Surgical  
General Procedure  
Surgical Sealants
A glue like material, made up of biomaterials, that is used to close up surgical incisions.

Target Products:

  • Fusion Medical Proceed
  
Ophthalmology
Diagnostic  
Imaging  
Ultrasound Systems
An imaging modality that takes advantage of acoustic variances of different body tissues.

Buyer Products:

  • OcuScan RxP Ophthalmic Ultrasound System
  • Ultrascan Imaging System
  
Physical Examination  
Eye Mapping
Devices that map the surface of the eye.

Buyer Products:

  • EYEMAP EH-290 Corneal Topography System
  
Refractive Analysis
Systems that measure refractive aberrations (vision disorder) through use of light refraction analysis.

Buyer Products:

  • LADARWave Diagnostic System
  
Surgical
General Procedure  
Accessories
Components used to assist in a variety of ophthalmic surgeries, such as light probes, light source, sutures, needles and other similar items.

Buyer Products:

  • Wide-Angle Illuminator
  • End-Irrigator Illuminator
  • ISPAN Intraocular Gases
  
Instruments  
Electrical  
Electrosurgical  
Bipolar Attachments
Devices used to perform electrosurgical procedures specifically on the eyes.

Buyer Products:

  • Next Generation Vitroretinal System
  • Accurus Vitreoretinal Surgical System Series
  • Grieshaber Hand-Held Instruments
  
Laser Systems
A laser that uses Argon gas as the active medium, doped to provide the energy states necessary for lasing.

Buyer Products:

  • Next Generation Vitreoretinal Laser
  • WaveLight FS200
  
Manual Instruments
Devices used to perform surgery on the eye or related area that do not require electrical power, such as blades, scalpels, cannulas, curettes, forceps, retractors, speculums and other similar items.

Buyer Products:

  • Custom Pak
  • BioSorb Sutures
  • Mackool Sideport Blade
  • Alcon Closure System
  
Procedure/Region Specific
Cataract
Instruments  
Electrical  
Phacoemulsification
A set of instruments that are used to surgically remove cataracts.

Buyer Products:

  • Laureate Compact Phacoemulsification System
  • OZil Torsional Handpiece
  • Infiniti Cataract Extraction System
  • Series 20000 Legacy
  • Universal-II Phaco Emulsification System
  
Manual Instruments
Devices used to perform cataract surgery that do not require electrical power, such as blades, scalpels, forceps, lens insertion systems and other similar items.

Buyer Products:

  • A-OK Surgical Knives
  • ClearCut Dual-Bevel Knives
  
Intraocular Lenses  
Foldable
Intraocular lens that can be rolled or folder for easier insertion.

Buyer Products:

  • AcrySof IQ Toric IOL
  • AcrySof Intraocular Lens Series
  • AcrySof IQ ReSTOR
  • AcrySof IQ Intraocular Lens
  
Viscoelastics
Material that can be applied to decrease resistance between two parts of the eye and promote healing and repair of damaged eye tissue.

Buyer Products:

  • DisCoVisc Viscoelastic
  • Viscoat Viscoelastic
  • ProVisc Viscoelastic
  • Improved Viscoelastic
  • DuoVisc Viscoelastic System
  • Cellugel Viscoelastic

Target Products:

  • Hylenex (Recombinant Human Hyaluronidase)
Refractive (Vision Correction)  
Instruments  
Electrical  
Laser Systems
Laser systems designed to use for refractive vision correction.

Buyer Products:

  • ALLEGRETTO WAVE Excimer Laser System
  • LADARVision 4000 Laser
  • CustomCornea Wavefront System
  • LADAR 6000 Excimer Laser/System
  
Manual Instruments
Devices used for refractive vision correction procedures that do not require electrical power, such as blades, knives and scalpels.

Buyer Products:

  • AcrySert
  
Retinal Therapy  
Implants  
Retinal Detachment
Devices that are implanted into the eye to hold a retina in place that has become detached from the back of the eyeball.

Buyer Products:

  • SILIKON 1000 (Purified Polydimethylsiloxane)
  • Perfluoron Perfluorocarbon Liquid
  
Instruments  
Electrical  
Lasers  
Systems
Complete set of instruments to perform laser surgery on the retina.

Buyer Products:

  • PUREPOINT Laser
  • Eyelite Photocoagulator
  
Treatment  
Dry Eye  
Lubricants
Devices used to alleviate low level of moisture in eye tissue by adding fluid.

Buyer Products:

  • Opti-Tears
  • Tears Naturale Series
  • Bion Tears
  • OTC Eye Lubricant
  
Punctal Plug
Device used to block the ducts used to drain liquid away from the eye surface.

Buyer Products:

  • Tears Naturale Punctal Plugs
  
Vision Correction  
Contact Lenses  
Accessories  
Lubricants
Material that decreases the resistance between the contact lens and eye lid or contact lens and cornea.

Buyer Products:

  • Clerz Plus
  • Advanced Rewetting Drop
  
Solutions/Disinfectants
Materials used to clean and maintain contact lenses.

Buyer Products:

  • No Rub Opti-Free Express
  • Opti-Free SupraClens
  • Opti-One
  • New Contact Lens Disinfectant
  • OPTI-FREE RepleniSH Multipurpose
  
Orthopedics  
Surgical  
Procedure Specific  
Bone Loss Reconstruction  
General  
Bone Fillers
Devices used to fill the formed bone cavity with hardening material.

Target Products:

  • Actifuse
  • Tricos T Bone Void Filler
  
Radiology  
X-Ray  
Contrast Agents  
Injectable
Introduced to the body via a needle.

Buyer Products:

  • Fluorescite Ophthalmic Solution (Fluorescein)
  
Respiratory  
Treatment  
Assisted Breathing  
Intubation  
Breathing Circuits
Instrument used to measure respiratory parameters such as pressure.

Target Products:

  • Baxter Isoflex Series Breathing Circuits
  
Transfusion Medicine  
Blood Collection  
Accessories  
Collection/Storage
Devices, usually polymer plastic bags used for collection and subsequent storage of blood and blood components. Specific additives may or may not be incorporated to prevent the collected blood from clotting.

Target Products:

  • Cryocyte Freezing Containers
  
Apheresis Systems  
Plasma
Systems which separate and collect the plasma component of human blood while returning other blood components to the donor.

Target Products:

  • Fenwal Amicus
  
Platelets
Systems which separate and collect the platelet cell component of human blood while returning other blood components to the donor.

Target Products:

  • Fenwal Amicus
  
Red Blood Cells
Systems which separate and collect the red cell component of human blood while returning other blood components to the donor.

Target Products:

  • Fenwal Amicus
  
Blood Washers
Instruments used to wash blood cells in preparation for usage; they are often used to prepare frozen red blood cells for transfusion.

Target Products:

  • Cytomate Cell Processing System
  
Filtration Systems
Medical devices used to filter leukocytes from blood during the transfusion process.

Target Products:

  • Sepacell RZ-2000
  • Sepacell Leukocyte Reduction Filters
  
Viral Inactivation  
Plasma
Medical devices and technology which destroy infectious agents such as viruses in donor plasma without damaging the integrity of the plasma proteins.

Target Products:

  • Helinx Intercept Plasma System
  
Platelets
Medical devices and technology which destroy infectious agents such as viruses in blood products (platelets) without damaging the integrity of the donor platelet cells.

Target Products:

  • Helinx Intercept Platelet System
  
Red Blood Cells
Medical devices and technology which destroy infectious agents such as viruses in donor blood without damaging the integrity of the donor red blood cells.

Target Products:

  • Helinx Intercept Red Blood Cell System
  
Urology  
Surgical  
General Procedure  
Minimally Invasive/Cystoscopy  
Irrigation Pumps/Systems
Surgical instruments that pump fluids to irrigate/moisten the surface of the urinary organs

Target Products:

  • Irrigation Set Series
  
Treatment  
Renal  
Hemodialysis  
Components  
Concentrates
Chemicals used in hemodialysis.

Target Products:

  • Althin Biopharm
  
Dialysate Parameter Monitors
Medical products used to monitor parameters such as fluid pressure, concentration, pH etc. during dialysis procedures.

Target Products:

  • Althin Biopharm Hemavision
  
Filtration  
Dialyzers
The instrument or medium used to effect chemical dialysis which allows for the diffusion of waste products and excess water into a dialysate solution.

Target Products:

  • Althin Altra Flux
  
Hemofilters
Filters used to separate the blood from the waste components during dialysis through a convection process by creating negative pressure to draw out solute particles without using a dialysate solution.

Target Products:

  • Renalflo II
  
Systems
A complete set of devices that act as a kidney to remove waste from the circulatory system.

Target Products:

  • Althin AltraTouch 1000
  
Peritoneal Dialysis  
Components  
Solutions
Chemical agents used in peritoneal dialysis.

Target Products:

  • Extraneal (Icodextrin)
  • Dianeal Series
  
Systems  
Automated Peritoneal Dialysis (APD)
Complete set of instruments and devices that cycle solution to and from the patient's peritoneum during sleep.

Target Products:

  • HomeChoice Automated
  
Continuous Ambulatory (CAPD)
Complete set of instruments and devices that perform peritoneal dialysis that can be moved around with the patient.

Target Products:

  • UltraBag System
  
Vascular  
Surgical  
General Procedure  
Accessories  
Introducers
Devices used to provide percutaneous introduction of catheters, interventional devices, and temporary pacing leads into the vasculature.

Target Products:

  • V-Link Luer-Activated Device (LAD)
  
Vessel Closure
Devices used to close and repair vascular structures, including both complete systems and associated clamps, felts and pledgets.

Target Products:

  • Fusion Medical FloSeal FAST
  
Nutritional Health
Dietary/Naturopathic Supplements
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.

Buyer Products:

  • ICAPS Enhanced Formulation

Target Products:

  • Baxter Inernational Inc.
Outsourced Biomedical Services  
Development/Manufacturing Services  
Contract Manufacturing Organizations (CMO)  
Biopharmaceutical OEM  
Final Dosage Forms
Contract Manufacturing Organizations (CMO) that produce large quantities of drug products in final dosage forms ready to be sold to end users.

Target Products:

  • Baxter Bioscience
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Moog Inc. n/a 2,037.931 16.99 n/a 0.94 n/a 7.99
Akorn, Inc. n/a 554.773 25.42 n/a 6.42 5.46 6.63
Buyer
  Pfizer Inc. n/a 163,500.198 19.81 8.92 2.41 2.43 n/a
Johnson & Johnson n/a 162,937.406 12.22 11.59 2.65 2.55 6.63
Target
  E.I. Du Pont de Nemours And Company n/a 51,321.042 16.98 13.36 1.57 1.48 12.97
Fresenius Medical Care AG & Co. (ADR) n/a 21,506.446 21.98 17.53 1.78 1.64 n/a
Hospira, Inc. n/a 9,322.833 26.10 12.52 2.38 2.25 7.87
Talecris Biotherapeutics Holdings Corp n/a 3,416.054 20.57 13.99 2.13 1.98 5.59
Crucell N.V. (ADR) n/a 2,926.023 n/a 40.01 6.55 n/a 3.34
Moog Inc. n/a 2,037.931 16.99 n/a 0.94 n/a 7.99
NxStage Medical, Inc. n/a 1,201.884 n/a -558.00 6.71 5.67 14.30
ICU Medical, Incorporated n/a 611.294 19.76 16.69 2.15 2.01 2.37
Akorn, Inc. n/a 554.773 25.42 n/a 6.42 5.46 6.63
Omnicell, Inc. n/a 499.876 102.19 39.92 2.25 2.08 2.15
Cytori Therapeutics Inc. (USA) n/a 405.317 n/a -14.31 38.13 27.87 21.86
BioTime, Inc. n/a 351.558 n/a n/a 95.51 n/a 15.43
YM BioSciences Inc. (USA) n/a 282.692 n/a -17.47 146.60 50.27 3.89
Nymox Pharmaceutical Corporation n/a 260.917 n/a 27.48 377.34 n/a n/a
CryoLife, Inc. n/a 155.976 39.55 18.09 1.34 1.33 1.48
PharmAthene, Inc. n/a 150.704 n/a -328.00 7.18 4.13 15.28
Celldex Therapeutics, Inc. n/a 134.633 n/a -3.52 2.88 13.58 3.41
Aastrom Biosciences, Inc. n/a 103.107 n/a -3.50 407.56 40.28 32.65
SeraCare Life Sciences, Inc. n/a 74.230 10.60 12.19 1.50 1.54 2.31
Hemispherx BioPharma, Inc n/a 64.240 n/a -4.27 474.87 124.63 1.42
Bionovo Inc. n/a 33.119 n/a n/a 53.97 16.23 6.20

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Bayer AG (ADR) n/a 65,279.259 39.48 10.31 1.40 1.26 n/a
Allergan, Inc. n/a 22,861.234 38,801.12 17.90 4.65 4.37 13.27
Landec Corporation n/a 160.347 30.91 19.16 0.60 0.60 1.94
Synergetics USA Inc. n/a 139.073 22.19 25.45 2.66 2.55 6.07
NovaBay Pharmaceuticals, Inc. n/a 53.911 n/a -9.67 5.53 n/a 5.14
Kyowa Hakko Kogyo Co., Ltd. n/a n/a n/a n/a n/a n/a n/a
Target
  CA, Inc. n/a 12,266.775 16.58 12.19 2.74 2.61 n/a
Ariba, Inc. n/a 2,942.739 52.31 66.12 8.04 7.37 21.81
Nektar Therapeutics n/a 1,119.335 n/a -9.57 7.04 13.62 79.04
Halozyme Therapeutics, Inc. n/a 694.658 n/a -15.38 50.98 35.74 34.13
Medidata Solutions, Inc. n/a 619.267 27.14 21.11 3.72 3.38 16.13
CapLease, Inc. n/a 357.863 n/a 7.34 2.15 2.12 2.14
CRA International, Inc. n/a 275.960 140.78 17.78 0.89 0.95 2.49
HealthStream, Inc. n/a 174.136 41.91 31.35 2.65 2.32 6.12
Dyax Corp. n/a 173.730 n/a -11.64 3.38 3.72 65.98
Flamel Technologies S.A. (ADR) n/a 140.457 n/a 9.11 3.79 3.87 n/a
Angiotech Pharmaceuticals, Inc. (USA) n/a 1.874 n/a n/a 0.01 n/a n/a

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  LCA-Vision Inc. n/a 126.910 n/a -40.59 1.27 1.34 4.08
PT Tempo Scan Pacific Tbk n/a n/a n/a n/a n/a n/a n/a
Target
  DaVita Inc. n/a 8,320.320 20.51 15.07 1.29 1.24 n/a
United Therapeutics Corporation n/a 3,800.784 35.89 19.09 6.29 5.02 4.30
Amylin Pharmaceuticals, Inc. n/a 1,591.612 n/a -11.69 2.38 2.71 4.63
Cerus Corporation n/a 129.948 n/a -10.00 5.62 4.60 6.35
Threshold Pharmaceuticals, Inc. n/a 88.809 n/a -5.94 n/a 6.53 17.97
Accentia Biopharmaceuticals, Inc n/a 35.689 n/a n/a 3.41 n/a n/a
Advanced Life Sciences Holdings, Inc. n/a 1.834 n/a n/a 2.42 n/a n/a
PT Kalbe Farma Tbk n/a n/a n/a n/a n/a n/a n/a
Sobhan Pharmaceutical Co n/a n/a n/a n/a n/a n/a n/a
PT Enseval Putera Megatrading Tbk n/a n/a n/a n/a n/a n/a n/a
Suhail Bahwan Group (Holding) LLC n/a n/a n/a n/a n/a n/a n/a
The Olayan Group n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  GlaxoSmithKline plc (ADR) n/a 206,435.142 82.06 9.84 4.66 4.61 n/a
Novartis AG (ADR) n/a 145,860.552 14.89 9.75 2.83 2.60 n/a
Target
  Celgene Corporation n/a 25,997.152 29.52 15.17 7.17 5.84 30.98
Cardinal Health, Inc. n/a 14,752.459 15.43 14.22 0.15 0.15 12.95
DaVita Inc. n/a 8,320.320 20.51 15.07 1.29 1.24 n/a
United Therapeutics Corporation n/a 3,800.784 35.89 19.09 6.29 5.02 4.30
Haemonetics Corporation n/a 1,700.611 27.01 18.68 2.52 2.31 3.89
Amylin Pharmaceuticals, Inc. n/a 1,591.612 n/a -11.69 2.38 2.71 4.63
Nektar Therapeutics n/a 1,119.335 n/a -9.57 7.04 13.62 79.04
The Medicines Company n/a 860.158 8.22 11.03 1.97 1.83 3.15
Halozyme Therapeutics, Inc. n/a 694.658 n/a -15.38 50.98 35.74 34.13
Cangene Corporation n/a 177.656 21.90 n/a 1.15 n/a 0.87
Cornerstone Therapeutics, Inc. n/a 177.076 18.86 13.17 1.41 1.45 3.78
Dyax Corp. n/a 173.730 n/a -11.64 3.38 3.72 65.98
Flamel Technologies S.A. (ADR) n/a 140.457 n/a 9.11 3.79 3.87 n/a
Cerus Corporation n/a 129.948 n/a -10.00 5.62 4.60 6.35
Oncothyreon Inc. n/a 125.169 n/a -6.27 6,939.45 166.28 7.48
Threshold Pharmaceuticals, Inc. n/a 88.809 n/a -5.94 n/a 6.53 17.97
Accentia Biopharmaceuticals, Inc n/a 35.689 n/a n/a 3.41 n/a n/a
Angiotech Pharmaceuticals, Inc. (USA) n/a 1.874 n/a n/a 0.01 n/a n/a
Advanced Life Sciences Holdings, Inc. n/a 1.834 n/a n/a 2.42 n/a n/a
Suhail Bahwan Group (Holding) LLC n/a n/a n/a n/a n/a n/a n/a
PT Enseval Putera Megatrading Tbk n/a n/a n/a n/a n/a n/a n/a
EIS Eczacibasi Ilac Sanayi ve Ticaret A.S. n/a n/a n/a n/a n/a n/a n/a
Sobhan Pharmaceutical Co n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 7,179.0 12,843.0 20,022.0
Other Revenue 0.0 0.0 0.0
Total Revenue 7,179.0 12,843.0 20,022.0
Cost of Revenue 1,675.0 6,885.0 8,560.0
SG&A Expense 2,070.0 2,782.0 4,852.0
Depreciation & Amortization 60.0 0.0 60.0
Research & Development 747.0 881.0 1,628.0
Interest Expense 0.0 0.0 0.0
Other Operating Expense 152.0 0.0 152.0
Unusual Expense (Income) 0.0 221.0 221.0
Total Expenses 4,704.0 10,769.0 15,473.0
Operating Income 2,475.0 2,074.0 4,549.0
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng 36.0 -87.0 -51.0
Other, Net 16.0 -97.0 -81.0
Income Before Taxes 2,527.0 1,890.0 4,417.0
Income Taxes 317.0 463.0 780.0
Income After Taxes 2,210.0 1,427.0 3,637.0
Minority Interest (IS) 0.0 -7.0 -7.0
Net Income - Excl. Xord. Items 2,210.0 1,420.0 3,630.0
Net Income - Incl. Xord. Items 2,210.0 1,420.0 3,630.0
Income Avail. to Common 2,210.0 1,420.0 3,630.0
Share Items
Basic Avg. Shares Outstanding 302.3 582.0 884.3
Basic EPS - Excl. Xord. Items 7.31 2.44 4.11
Basic EPS - Incl. Xord. Items 7.31 2.44 4.11
Full Dilution Adjustment 0.0 0.0 0.0
Fully Diluted Shares Outstanding 305.1 586.0 891.1
F.D. EPS - Excl. Xord. Items 7.24 2.42 4.07
F.D. EPS - Incl. Xord. Items 7.24 2.42 4.07
Dividends Per Common Share 3.70 1.18 4.88
Balance Sheet
Assets
Cash and Equivalents 2,525.0 2,685.0 5,210.0
ST Investments 889.0 0.0 889.0
Accounts Receivable 1,483.0 2,265.0 3,748.0
Inventory 693.0 2,371.0 3,064.0
Prepayments and Advances 0.0 345.0 345.0
Other Current Assets 479.0 323.0 802.0
Current Assets 6,069.0 7,989.0 14,058.0
PPE 0.0 10,591.0 10,591.0
Accum D&A 0.0 -5,331.0 -5,331.0
PPE, Net 1,388.0 5,260.0 6,648.0
Goodwill & Intangibles 1,786.0 2,046.0 3,832.0
Long Term Investments 398.0 0.0 398.0
Other Assets 0.0 0.0 0.0
Other LT Assets 432.0 1,725.0 2,157.0
Total Assets 10,073.0 17,489.0 27,562.0
Liabilities
Accounts Payable 370.0 0.0 370.0
Payable/Accrued 0.0 4,017.0 4,017.0
ST Debt 337.0 15.0 352.0
Curr Port of LTD & Cap Lease Oblg 62.0 9.0 71.0
Other (Current) Liabilities 1,022.0 0.0 1,022.0
Current Liab. 1,791.0 4,041.0 5,832.0
LT Debt 0.0 4,363.0 4,363.0
Total LT Debt 0.0 4,363.0 4,363.0
Minority Interest (BS) 0.0 229.0 229.0
Deferred Taxes 65.0 0.0 65.0
Other LT Liab. 965.0 2,289.0 3,254.0
Total Liabilities 2,821.0 10,922.0 13,743.0
Shareholders Equity
Common Stock 42.0 683.0 725.0
Additional Paid in Capital 1,669.0 5,753.0 7,422.0
Retained Earnings 5,706.0 7,925.0 13,631.0
Treasure Stock -263.0 -5,655.0 -5,918.0
Other Equity 98.0 -2,139.0 -2,041.0
Total Equity 7,252.0 6,567.0 13,819.0
Total Liab. & Equity 10,073.0 17,489.0 27,562.0
Shares Outstanding 301.9 580.7 882.7
Cash Flow
Operating Cash Flow
CF Net Income 2,210.0 1,427.0 3,637.0
CF Depreciation 212.0 685.0 897.0
CF Amortization 60.0 0.0 60.0
CF Deferred Taxes 4.0 76.0 80.0
Other Non-Cash Items 55.0 1,104.0 1,159.0
Change in Working Capital -166.0 -289.0 -455.0
Total Cash From Operating Activities 2,375.0 3,003.0 5,378.0
Investing Cash Flow (not calculated)
Capital Expenditures -446.0 -963.0 -1,409.0
Other Investing Cash Flows -1,259.0 -301.0 -1,560.0
Total Cash From Investing Activities -1,705.0 -1,264.0 -2,969.0
Financing Cash Flow (not calculated)
Dividends Paid -1,037.0 -688.0 -1,725.0
Purchase Or Sale of Stock 136.0 -1,453.0 -1,317.0
Purchase and Retirement of Debt -306.0 -498.0 -804.0
Other Financing Cash Flow 57.0 334.0 391.0
Total Cash From Financing Activities -1,150.0 -1,716.0 -2,866.0
Exchange Rate Effects -2.0 -124.0 -126.0
Net Change in Cash -482.0 -101.0 -583.0
Cash Taxes Paid 0.0 353.0 353.0
Cash Interest Paid 0.0 109.0 109.0